About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Astrazeneca Pharma India Ltd.
BSE Code
506820
ISIN Demat
INE203A01020
Book Value
271.74
NSE Code
ASTRAZEN
Dividend Yield %
0.37
Market Cap
162421.25
P/E
198.27
EPS
32.77
Face Value
2
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
20-Dec-2024
6496.55
6513.75
6435.05
6496.85
540
3502571
19-Dec-2024
6451.50
6515.10
6393.65
6505.85
207
1335902
18-Dec-2024
6566.55
6632.95
6450.50
6480.70
425
2770701
17-Dec-2024
6744.60
6744.60
6476.80
6532.25
634
4157603
16-Dec-2024
6512.05
6722.00
6512.05
6607.75
443
2951647
13-Dec-2024
6591.05
6658.35
6505.80
6603.60
224
1472665
12-Dec-2024
6605.05
6675.00
6560.00
6636.00
308
2036284
11-Dec-2024
6630.00
6640.75
6590.05
6595.05
271
1791038
10-Dec-2024
6748.95
6753.95
6603.20
6634.15
413
2750600
09-Dec-2024
6670.05
6744.55
6585.45
6641.80
1143
7615368
06-Dec-2024
6617.80
6690.20
6601.55
6632.55
751
4991202
05-Dec-2024
6706.40
6712.00
6580.70
6630.55
893
5911567
04-Dec-2024
6500.05
6730.00
6500.05
6660.80
1795
11948073
03-Dec-2024
6788.90
6853.35
6545.95
6597.95
1622
10893023
02-Dec-2024
6585.00
6759.80
6585.00
6712.65
1229
8216072
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.